Clinical Trial Update: Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether pre-transplant sofosbuvir with ribavirin reduces hepatitis C recurrence after liver transplantation. The study is completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Hepatocellular Carcinoma

Drugs mentioned

• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-05-28